Published in Mol Cell Biol on January 22, 2007
Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet (2007) 3.08
New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res (2010) 2.82
DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol (2007) 2.47
Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells. Cell Cycle (2012) 2.09
Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) (2009) 1.89
Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc Natl Acad Sci U S A (2008) 1.74
Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase. Genes Dev (2010) 1.56
Mechanisms and pathways of growth failure in primordial dwarfism. Genes Dev (2011) 1.56
Roles of Chk1 in cell biology and cancer therapy. Int J Cancer (2013) 1.37
DNA damage tolerance: a double-edged sword guarding the genome. Transl Cancer Res (2013) 1.33
The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. J Biol Chem (2010) 1.33
Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. Proc Natl Acad Sci U S A (2009) 1.29
Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition. J Biol Chem (2009) 1.17
Expanded roles for Chk1 in genome maintenance. J Biol Chem (2008) 1.15
Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene (2009) 1.14
Targeting the checkpoint kinase Chk1 in cancer therapy. Cell Cycle (2010) 1.11
Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery. Hum Mol Genet (2010) 1.06
A conserved proliferating cell nuclear antigen-interacting protein sequence in Chk1 is required for checkpoint function. J Biol Chem (2008) 1.02
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J (2010) 1.00
STAT3 modulates the DNA damage response pathway. Int J Exp Pathol (2010) 1.00
Checkpoint kinase 1 prevents cell cycle exit linked to terminal cell differentiation. Mol Cell Biol (2011) 0.98
WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes. J Cell Sci (2011) 0.97
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. Am J Pathol (2011) 0.95
Roles of human AND-1 in chromosome transactions in S phase. J Biol Chem (2009) 0.95
Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2. Blood (2011) 0.95
Global regulation of genome duplication in eukaryotes: an overview from the epifluorescence microscope. Chromosoma (2008) 0.94
Chk1-cyclin A/Cdk1 axis regulates origin firing programs in mammals. Chromosome Res (2010) 0.93
γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments. BMC Cancer (2014) 0.91
A new in vitro system for activating the cell cycle checkpoint. Cell Cycle (2011) 0.90
Replication licensing and the DNA damage checkpoint. Front Biosci (Landmark Ed) (2009) 0.90
Autoregulatory mechanisms of phosphorylation of checkpoint kinase 1. Cancer Res (2012) 0.89
Chk1 phosphorylation during mitosis: a new role for a master regulator. Cell Cycle (2009) 0.89
Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors. Oncogene (2014) 0.87
The fork and the kinase: a DNA replication tale from a CHK1 perspective. Mutat Res Rev Mutat Res (2014) 0.87
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response. Br J Cancer (2015) 0.86
Protein phosphatase 1γ is responsible for dephosphorylation of histone H3 at Thr 11 after DNA damage. EMBO Rep (2010) 0.84
Conserved ATRMec1 phosphorylation-independent activation of Chk1 by single amino acid substitution in the GD domain. Cell Cycle (2009) 0.81
Response to DNA damage: why do we need to focus on protein phosphatases? Front Oncol (2013) 0.81
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design. Oncotarget (2015) 0.79
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival. Mol Cancer Ther (2011) 0.79
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development. J Neurosci (2015) 0.78
Host response during Yersinia pestis infection of human bronchial epithelial cells involves negative regulation of autophagy and suggests a modulation of survival-related and cellular growth pathways. Front Microbiol (2015) 0.78
KA1-targeted regulatory domain mutations activate Chk1 in the absence of DNA damage. Sci Rep (2015) 0.78
BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest. Int J Biochem Cell Biol (2012) 0.77
Centrosomes in the DNA damage response-the hub outside the centre. Chromosome Res (2016) 0.77
Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization. Int J Radiat Oncol Biol Phys (2012) 0.77
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss. Genes Chromosomes Cancer (2013) 0.77
Opposing effects of pericentrin and microcephalin on the pericentriolar material regulate CHK1 activation in the DNA damage response. Oncogene (2015) 0.76
Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage. J Biol Chem (2016) 0.76
Activation of CHK1 in Supporting Cells Indirectly Promotes Hair Cell Survival. Front Cell Neurosci (2017) 0.75
UNC45A localizes to centrosomes and regulates cancer cell proliferation through ChK1 activation. Cancer Lett (2014) 0.75
Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase. Oncotarget (2016) 0.75
Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling. PLoS One (2015) 0.75
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer (2016) 0.75
Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damage. Sci Rep (2017) 0.75
Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity. Sci Rep (2016) 0.75
UV Damage-Induced Phosphorylation of HBO1 Triggers CRL4DDB2-Mediated Degradation To Regulate Cell Proliferation. Mol Cell Biol (2015) 0.75
The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy. PLoS One (2017) 0.75
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science (2003) 18.29
ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer (2003) 16.06
Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev (2001) 12.46
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49
Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol (2000) 9.21
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol (2005) 8.27
Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature (2005) 7.45
ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev (2000) 7.28
ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol (2001) 7.26
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature (2005) 6.86
TopBP1 activates the ATR-ATRIP complex. Cell (2006) 6.29
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev (2000) 5.72
Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature (1993) 5.70
Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat Cell Biol (2003) 4.77
Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev (2002) 4.58
Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev (2000) 4.38
A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol (2002) 4.10
Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature (2005) 4.06
Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev (2000) 3.96
A kinase from fission yeast responsible for blocking mitosis in S phase. Nature (1995) 3.83
The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. J Cell Biol (1998) 3.13
The G2-phase DNA-damage checkpoint. Trends Cell Biol (2000) 2.64
Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol (2004) 2.63
Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J Biol Chem (2003) 2.54
Role for a Xenopus Orc2-related protein in controlling DNA replication. Nature (1996) 2.44
Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol (2005) 2.13
The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell (2000) 2.11
Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex. Oncogene (2006) 1.93
Chk2 activation and phosphorylation-dependent oligomerization. Mol Cell Biol (2002) 1.88
A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol (2002) 1.88
Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. J Biol Chem (2003) 1.82
Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest. J Cell Sci (2002) 1.75
Inactivation of mouse Hus1 results in genomic instability and impaired responses to genotoxic stress. Genes Dev (2000) 1.70
Genomic instability and endoreduplication triggered by RAD17 deletion. Genes Dev (2003) 1.64
Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation. Mol Biol Cell (2004) 1.46
Inhibition of Chk1 by activated PKB/Akt. Cell Cycle (2004) 1.38
Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem (2005) 1.35
Tetraploidy and tumor development. Cancer Cell (2005) 1.23
Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway. Curr Biol (2002) 1.19
Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1). Genes Cells (2006) 1.12
Interaction of 14-3-3 protein with Chk1 affects localization and checkpoint function. J Cell Sci (2004) 1.06
Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling event. J Biol Chem (2002) 1.03
Analyzing cell cycle checkpoints after ionizing radiation. Methods Mol Biol (2004) 1.01
Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability. Genes Cells (2005) 0.99
Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J (2002) 3.45
CT of internal hernias. Radiographics (2005) 2.75
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J (2004) 2.18
Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell (2008) 2.17
DNA damage checkpoints in mammals. Mutagenesis (2005) 2.05
Involvement of mammalian Mus81 in genome integrity and tumor suppression. Science (2004) 2.03
Anti-proliferative activity of silver nanoparticles. BMC Cell Biol (2009) 1.80
Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. EMBO J (2003) 1.68
Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality. Mol Cell Biol (2004) 1.63
Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol (2003) 1.63
A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol (2005) 1.63
Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase. Genes Dev (2010) 1.56
Hydrocephalus, situs inversus, chronic sinusitis, and male infertility in DNA polymerase lambda-deficient mice: possible implication for the pathogenesis of immotile cilia syndrome. Mol Cell Biol (2002) 1.40
Identification of MCM4 as a target of the DNA replication block checkpoint system. J Biol Chem (2003) 1.36
Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem (2005) 1.35
Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature (2013) 1.35
Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. Proc Natl Acad Sci U S A (2009) 1.29
A role for Brca1 in chromosome end maintenance. Hum Mol Genet (2006) 1.29
Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J Immunol (2005) 1.26
Yeast Nhp6A/B and mammalian Hmgb1 facilitate the maintenance of genome stability. Curr Biol (2005) 1.24
Genomic instability, defective spermatogenesis, immunodeficiency, and cancer in a mouse model of the RIDDLE syndrome. PLoS Genet (2011) 1.23
Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res (2002) 1.20
Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev (2004) 1.18
Human SAD1 kinase is involved in UV-induced DNA damage checkpoint function. J Biol Chem (2004) 1.17
Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1). Genes Cells (2006) 1.12
Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene (2004) 1.12
Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Cancer Res (2007) 1.09
Mechanisms of dNTP supply that play an essential role in maintaining genome integrity in eukaryotic cells. Cancer Sci (2010) 1.07
Regulation of yeast forkhead transcription factors and FoxM1 by cyclin-dependent and polo-like kinases. Cell Cycle (2010) 1.04
Functional interplay of p53 and Mus81 in DNA damage responses and cancer. Cancer Res (2007) 1.03
Chemical modification of biogenous iron oxide to create an excellent enzyme scaffold. Org Biomol Chem (2009) 1.02
Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China. Hepatol Res (2002) 1.02
Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y. J Biol Chem (2004) 1.01
DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine (Lond) (2010) 1.01
Genetic variation of the IL-28B promoter affecting gene expression. PLoS One (2011) 1.01
TAp73 is a downstream target of p53 in controlling the cellular defense against stress. J Biol Chem (2007) 1.01
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J (2010) 1.00
Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res (2002) 1.00
Maintenance of replication forks and the S-phase checkpoint by Cdc18p and Orp1p. Nat Cell Biol (2002) 1.00
DNA replication checkpoint control mediated by the spindle checkpoint protein Mad2p in fission yeast. J Biol Chem (2004) 0.98
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A (2011) 0.98
Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS One (2010) 0.98
DNA damage checkpoints and cancer. J Mol Histol (2006) 0.97
Telomere and telomerase modulation by the mammalian Rad9/Rad1/Hus1 DNA-damage-checkpoint complex. Curr Biol (2006) 0.97
A checkpoint control linking meiotic S phase and recombination initiation in fission yeast. Proc Natl Acad Sci U S A (2005) 0.97
Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci (2005) 0.97
Health impact and safety of engineered nanomaterials. Chem Commun (Camb) (2011) 0.97
Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase. Biochem Biophys Res Commun (2002) 0.96
Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cells. Genome Integr (2012) 0.96
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. Cancer Detect Prev (2008) 0.96
Short dysfunctional telomeres impair the repair of arsenite-induced oxidative damage in mouse cells. J Cell Physiol (2008) 0.96
Stretch-induced IL-6 secretion from endothelial cells requires NF-kappaB activation. Biochem Biophys Res Commun (2003) 0.93
Nuclear Chk1 prevents premature mitotic entry. J Cell Sci (2011) 0.93
Chk1-cyclin A/Cdk1 axis regulates origin firing programs in mammals. Chromosome Res (2010) 0.93
Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. J Cell Biochem (2013) 0.93
Checkpoints meet the transcription at a novel histone milestone (H3-T11). Cell Cycle (2008) 0.93
Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite. Cancer Res (2005) 0.92
Folate deficiency induces dysfunctional long and short telomeres; both states are associated with hypomethylation and DNA damage in human WIL2-NS cells. Cancer Prev Res (Phila) (2013) 0.91
Isoform-specific activation of protein kinase c in irradiated human fibroblasts and their bystander cells. Int J Biochem Cell Biol (2007) 0.91
Retracted Environmental toxicogenomics: a post-genomic approach to analysing biological responses to environmental toxins. Int J Biochem Cell Biol (2009) 0.91
Oxidative damage induced genotoxic effects in human fibroblasts from Xeroderma Pigmentosum group A patients. Int J Biochem Cell Biol (2008) 0.91
Increased protein stability of CDKN1C causes a gain-of-function phenotype in patients with IMAGe syndrome. PLoS One (2013) 0.91
Mei4p coordinates the onset of meiosis I by regulating cdc25+ in fission yeast. Proc Natl Acad Sci U S A (2007) 0.90
Anaphase-promoting complex/cyclosome-cdh1 mediates the ubiquitination and degradation of TRB3. Biochem Biophys Res Commun (2010) 0.90
Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer. Genes Chromosomes Cancer (2008) 0.90
Annexin-1 protects MCF7 breast cancer cells against heat-induced growth arrest and DNA damage. Cancer Lett (2010) 0.89
Essential role of Chk1 in S phase progression through regulation of RNR2 expression. Biochem Biophys Res Commun (2008) 0.89
Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells. Int J Oncol (2007) 0.89
A role for Mus81 in the repair of chromium-induced DNA damage. Mutat Res (2008) 0.88
Hemobilia caused by pseudoaneurysm of the cystic artery. J Gastroenterol Hepatol (2004) 0.86
Disruption of the novel gene fad104 causes rapid postnatal death and attenuation of cell proliferation, adhesion, spreading and migration. Exp Cell Res (2008) 0.85
Stable intrachromosomal biomarkers of past exposure to densely ionizing radiation in several chromosomes of exposed individuals. Radiat Res (2004) 0.85
Telomere-mediated chromosomal instability triggers TLR4 induced inflammation and death in mice. PLoS One (2010) 0.85
Human embryonic stem cells may display higher resistance to genotoxic stress as compared to primary explanted somatic cells. Stem Cells Dev (2008) 0.85
Protein phosphatase 1γ is responsible for dephosphorylation of histone H3 at Thr 11 after DNA damage. EMBO Rep (2010) 0.84
Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics. Mol Cancer Ther (2007) 0.84
Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Microbiol Immunol (2004) 0.84
Inhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instability. Genome Integr (2010) 0.84
Enhanced genotoxicity of silver nanoparticles in DNA repair deficient Mammalian cells. Front Genet (2012) 0.84
Loss of p27(Kip1) accelerates DNA replication after partial hepatectomy in mice. J Surg Res (2003) 0.82
Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C. J Pharmacol Sci (2011) 0.82
Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. Mutat Res (2007) 0.82
Comparison of lymphocyte apoptotic index and qualitative DNA damage in yoga practitioners and breast cancer patients: A pilot study. Int J Yoga (2013) 0.81
Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation. Int J Cancer (2008) 0.81
Histone H1 expression in human prostate cancer tissues and cell lines. Pathol Int (2011) 0.81
Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling. EMBO J (2012) 0.81
Telomere attrition and genomic instability in xeroderma pigmentosum type-b deficient fibroblasts under oxidative stress. J Cell Mol Med (2009) 0.81
Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells. Genes Chromosomes Cancer (2012) 0.81
Response to DNA damage: why do we need to focus on protein phosphatases? Front Oncol (2013) 0.81
Dual mode of regulation of cell division cycle 25 A protein by TRB3. Biol Pharm Bull (2010) 0.81